Data for Boston Scientific’s Watchman FLX implant met the primary endpoint in a new study. The stock is falling anyway.
Infections of the BA.3.2 variant of the COVID-causing coronavirus are still at very low levels, but experts are concerned it ...
The arrival of AI-generated research papers marks a turning point that could radically accelerate discovery—or drown it in ...
1d
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the company's latest trial ...
Investor's Business Daily on MSN
Boston Scientific just took a 9% header. Why analysts are still bullish
Boston Scientific stock tumbled Monday on mixed test results for its Watchman device in patients at risk of having a stroke.
Biointelli Corporation today announced the launch of Biointelli Predict, the first commercial intelligence platform built on Scientific Signal Intelligence™ (SSI) — a new category designed to detect ...
A paper built entirely by artificial intelligence did not arrive with a flashy headline. At its core, the study delivers a surprisingly flat result: a promising technique that does nothing to improve ...
A robot named Adam was the first of its kind to do science. Adam mimicked a biologist. After coming up with questions to ask about yeast, the machine tested those questions inside a robotic laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results